Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver’s Quality of Life

A randomized, 13-weeks, placebo-controlled double-blind study in 125 subjects aged 2–17.5 years with Autism Spectrum Disorder or Smith-Magenis syndrome and insomnia demonstrated efficacy and safety of easily-swallowed prolonged-release melatonin mini-tablets (PedPRM; 2–5 mg) in improving sleep durat...

Descripción completa

Detalles Bibliográficos
Autores principales: Schroder, Carmen M., Malow, Beth A., Maras, Athanasios, Melmed, Raun D., Findling, Robert L., Breddy, John, Nir, Tali, Shahmoon, Shiri, Zisapel, Nava, Gringras, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647439/
https://www.ncbi.nlm.nih.gov/pubmed/31079275
http://dx.doi.org/10.1007/s10803-019-04046-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647439/
https://www.ncbi.nlm.nih.gov/pubmed/31079275
http://dx.doi.org/10.1007/s10803-019-04046-5

Ejemplares similares